Akoya BioSciences, Inc.Akoya BioSciences, Inc.Akoya BioSciences, Inc.

Akoya BioSciences, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪111.12 M‬USD
‪−63.32 M‬USD
‪96.63 M‬USD
‪21.86 M‬
Beta (1Y)

About Akoya BioSciences, Inc.

Brian McKelligon
Employees (FY)
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Revenue to profit conversion
Debt level and coverage
Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AKYA is 2.31 USD — it has increased by 2.67% in the past 24 hours. Watch Akoya BioSciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Akoya BioSciences, Inc. stocks are traded under the ticker AKYA.
AKYA stock has risen by 8.96% compared to the previous week, the month change is a 1.76% rise, over the last year Akoya BioSciences, Inc. has showed a 69.16% decrease.
We've gathered analysts' opinions on Akoya BioSciences, Inc. future price: according to them, AKYA price has a max estimate of 8.00 USD and a min estimate of 4.00 USD. Watch AKYA chart and read a more detailed Akoya BioSciences, Inc. stock forecast: see what analysts think of Akoya BioSciences, Inc. and suggest that you do with its stocks.
AKYA reached its all-time high on Apr 16, 2021 with the price of 28.96 USD, and its all-time low was 1.88 USD and was reached on May 23, 2024. View more price dynamics on AKYA chart.
See other stocks reaching their highest and lowest prices.
AKYA stock is 4.25% volatile and has beta coefficient of 2.68. Track Akoya BioSciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Akoya BioSciences, Inc. there?
Today Akoya BioSciences, Inc. has the market capitalization of ‪114.08 M‬, it has decreased by 0.48% over the last week.
Yes, you can track Akoya BioSciences, Inc. financials in yearly and quarterly reports right on TradingView.
Akoya BioSciences, Inc. is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
AKYA earnings for the last quarter are −0.48 USD per share, whereas the estimation was −0.29 USD resulting in a −66.23% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Akoya BioSciences, Inc. earnings.
Akoya BioSciences, Inc. revenue for the last quarter amounts to ‪18.35 M‬ USD, despite the estimated figure of ‪24.35 M‬ USD. In the next quarter, revenue is expected to reach ‪23.67 M‬ USD.
AKYA net income for the last quarter is ‪−23.48 M‬ USD, while the quarter before that showed ‪−10.80 M‬ USD of net income which accounts for −117.40% change. Track more Akoya BioSciences, Inc. financial stats to get the full picture.
No, AKYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 13, 2024, the company has 330.00 employees. See our rating of the largest employees — is Akoya BioSciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Akoya BioSciences, Inc. EBITDA is ‪−47.04 M‬ USD, and current EBITDA margin is −48.78%. See more stats in Akoya BioSciences, Inc. financial statements.
Like other stocks, AKYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Akoya BioSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Akoya BioSciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Akoya BioSciences, Inc. stock shows the sell signal. See more of Akoya BioSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.